https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Fri, 28 Jan 2022 09:18:39 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png https://mirror.vjregenmed.com 32 32 https://mirror.vjregenmed.com/video/adxuzr-4ok-spearhead-1-adp-a2m4-in-synovial-sarcoma-and-mrcls/ Sat, 03 Jul 2021 11:01:10 +0000 http://13.40.107.223/video/adxuzr-4ok-spearhead-1-adp-a2m4-in-synovial-sarcoma-and-mrcls/ Jo Brewer, PhD, Adaptimmune, Philadelphia, PA, introduces the ongoing Phase II SPEARHEAD-1 trial (NCT04044768), assessing the efficacy and safety of ADP-A2M4 in patients with synovial sarcoma or myxoid/round cell liposarcoma (MRCLS). The ADP-A2M4 SPEAR T-cell therapy targets the MAGE- A4 antigen presented by HLA-A2+ patients. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.

]]>